Meyos €2.3 million for improving lives of chronic kidney patients
Medtech startup Metyos has secured €2.3 million in pre-seed funding to advance its mission of improving the lives of chronic kidney disease (CKD) patients worldwide.
Source: outsourcing-pharma.com